Silicon Valley Capital Partners’s Novo Nordisk NVO Stock Holding History

Silicon Valley Capital Partners’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$10.1K	Hold	276	–	–	﹤0.01%	210
2025 Q4	$14K	Hold	276	–	–	﹤0.01%	191
2025 Q3	$15.3K	Buy	+276	New	+$16.2K	﹤0.01%	185
2025 Q2	–	Sell	-738	Closed	-$51.2K	–	321
2025 Q1	$51.2K	Hold	738	–	–	0.01%	127
2024 Q4	$63.5K	Sell	738 -802	-52%	-$86.7K	0.01%	122
2024 Q3	$183K	Buy	1,540 +4	+0.3%	+$533	0.02%	78
2024 Q2	$219K	Buy	1,536 +804	+110%	+$107K	0.03%	69
2024 Q1	$94K	Hold	732	–	–	0.01%	91
2023 Q4	$75.8K	Hold	732	–	–	0.01%	88
2023 Q3	$66.6K	Buy	732 +2	+0.3%	+$176	0.01%	93
2023 Q2	$59.1K	Buy	+730	New	+$59.6K	0.01%	95

Other funds holding NVO

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Silicon Valley Capital Partners's NVO Position: Q1 2026 in Review

Silicon Valley Capital Partners held its Novo Nordisk (NVO) position steady in Q1 2026 at 276 shares worth $10.1K. The position accounts for ﹤0.01% of the portfolio, ranked #210.

Silicon Valley Capital Partners first reported a position in NVO in Q2 2023 and has held it in 11 quarters since. The position peaked at $219K in Q2 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

Silicon Valley Capital Partners held 276 shares of Novo Nordisk worth $10.1K as of Q1 2026.
Silicon Valley Capital Partners left its Novo Nordisk share count unchanged in Q1 2026.
Novo Nordisk made up ﹤0.01% of Silicon Valley Capital Partners's portfolio in Q1 2026, its #210 holding.
Silicon Valley Capital Partners first reported a position in Novo Nordisk in Q2 2023 and has held it in 11 quarters since.
Silicon Valley Capital Partners's Novo Nordisk position peaked at $219K in Q2 2024.
1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Silicon Valley Capital Partners's 13F filing for Q1 2026, filed 19 May 2026.